Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).

نویسندگان

  • Michael Arzt
  • John S Floras
  • Alexander G Logan
  • R John Kimoff
  • Frederic Series
  • Debra Morrison
  • Kathleen Ferguson
  • Israel Belenkie
  • Michael Pfeifer
  • John Fleetham
  • Patrick Hanly
  • Mark Smilovitch
  • Clodagh Ryan
  • George Tomlinson
  • T Douglas Bradley
چکیده

BACKGROUND In the main analysis of the Canadian Continuous Positive Airway Pressure (CPAP) for Patients with Central Sleep Apnea (CSA) and Heart Failure Trial (CANPAP), CPAP had no effect on heart transplant-free survival; however, CPAP only reduced the mean apnea-hypopnea index to 19 events per hour of sleep, which remained above the trial inclusion threshold of 15. This stratified analysis of CANPAP tested the hypothesis that suppression of CSA below this threshold by CPAP would improve left ventricular ejection fraction and heart transplant-free survival. METHODS AND RESULTS Of the 258 heart failure patients with CSA in CANPAP, 110 of the 130 randomized to the control group and 100 of the 128 randomized to CPAP had sleep studies 3 months later. CPAP patients were divided post hoc into those whose apnea-hypopnea index was or was not reduced below 15 at this time (CPAP-CSA suppressed, n=57, and CPAP-CSA unsuppressed, n=43, respectively). Their changes in left ventricular ejection fraction and heart transplant-free survival were compared with those in the control group. Despite similar CPAP pressure and hours of use in the 2 groups, CPAP-CSA-suppressed subjects experienced a greater increase in left ventricular ejection fraction at 3 months (P=0.001) and significantly better transplant-free survival (hazard ratio [95% confidence interval] 0.371 [0.142 to 0.967], P=0.043) than control subjects, whereas the CPAP-CSA-unsuppressed group did not (for left ventricular ejection fraction, P=0.984, and for transplant-free survival, hazard ratio 1.463 [95% confidence interval 0.751 to 2.850], P=0.260). CONCLUSIONS These results suggest that in heart failure patients, CPAP might improve both left ventricular ejection fraction and heart transplant-free survival if CSA is suppressed soon after its initiation.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Screening for sleep-disordered breathing is recommended in patients with chronic heart failure.

The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure (CANPAP) trial was the first study to assess the effect of CPAP therapy in patients with chronic heart failure (CHF) and predominantly central sleep apnoea (CSA) on mortality [2]. Unfortunately, this study failed to demonstrate a prognostic benefit. However, there is ongoing debate as to how...

متن کامل

Ischemic Lesion Formation in Solitary Tract Nuclei During Central Sleep Apnea With Heart Failure.

1. Satake H, Sugimura K, Fukumoto Y, Fukuda K, Nakano M, Kondo M, et al. Effect of respiratory therapy on the prognosis of chronic heart failure patients complicated with sleep-disordered breathing: A pilot efficacy trial. Circ J 2016; 80: 130 – 138. 2. Momomura S, Seino Y, Kihara Y, Adachi H, Yasumura Y, Yokoyama H, et al; for the SAVIOR-C investigators. Adaptive servo-ventilation therapy for ...

متن کامل

Factors Affecting Patients’ Adherence to Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea Disorder: A Multi-Method Approach

Background: Continuous positive airway pressure (CPAP) is the gold standard therapy for treating obstructive sleep apnea (OSA) disorder. However, patients’ adherence to its regular use is poor. The present study aimed to determine the adherence rate to CPAP therapy by identifying factors affecting its regular use and its associated problems and discomforts among a sample population in Mashhad (...

متن کامل

Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing.

The Canadian Thoracic Society (CTS) published an executive summary of guidelines for the diagnosis and treatment of sleep disordered breathing in 2006⁄2007. These guidelines were developed during several meetings by a group of experts with evidence grading based on committee consensus. These guidelines were well received and the majority of the recommendations remain unchanged. The CTS embarked...

متن کامل

13-18 Vincenzo Patruno.qxd:-

Sleep breathing disorders (SBD) are commonly divided in three syndromes: obstructive sleep apnea syndrome (OSA), central sleep apnea-hypopnea syndrome (CSA) and Cheyne-Stokes breathing syndrome (CSR), the latter two both characterized by cyclic non-obstructive breathing patterns. Because the prevalence of CSA-CSR in chronic heart failure (CHF) population has been reported from 40% to 60%, CSA-C...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Circulation

دوره 115 25  شماره 

صفحات  -

تاریخ انتشار 2007